XML 123 R14.htm IDEA: XBRL DOCUMENT v3.20.1
DERIVATIVE LIABILITIES
12 Months Ended
Dec. 31, 2019
DERIVATIVE LIABILITIES  
8. DERIVATIVE LIABILITIES

The fair value of the Company’s derivative liabilities is estimated at the issuance date and is revalued at each subsequent reporting date. We estimate the fair value of derivative liabilities associated with our convertible notes payable, Series B preferred stock and warrants using a multinomial lattice model based on projections of various potential future outcomes. Where the number of warrants or common shares to be issued under these agreements is indeterminate, the Company has concluded that the equity environment is tainted, and all additional warrants and convertible debt and equity are included in the value of the derivatives.

 

The significant assumptions used in the valuation of the derivative liabilities at September 30, 2019 are as follows:

 

Conversion to stock

 

Monthly

 

Stock price on the valuation date

 

$ 0.0676

 

Conversion price

 

$

21.38 - $0.095

 

Risk free interest rates

 

1.49% - 2.74

% 

Years to maturity

 

 

15.0

 

Expected volatility

 

185%–363

% 

 

The value of our derivative liabilities was estimated as follows at December 31:

  

 

 

2019

 

 

2018

 

 

 

 

 

 

 

 

Convertible notes payable

 

$ 3,606,194

 

 

$ 7,809,054

 

Series B preferred stock

 

 

2,535,359

 

 

 

2,339,898

 

Warrants

 

 

19,342

 

 

 

214,153

 

 

 

 

 

 

 

 

 

 

Total

 

$ 6,160,895

 

 

$ 10,363,105

 

 

The calculation input assumptions are subject to significant changes from period to period and to management’s judgment; therefore, the estimated fair value of the derivative liability will fluctuate from period to period, and the fluctuation may be material.